Sophim today announced the acquisition of Novastell, a supplier of nutritional and functional ingredients. The transaction was finalized in September 2023, leading to an official presentation of the teams in Peyruis, in the south of France, in early 2024.
Last year, the French manufacturer of natural cosmetic ingredients, specialising in the production of squalane from vegetable origin, secured a EUR 20 million funding round to accelerate its growth.
Already strongly present in the cosmetics and pharmaceutical sectors, Sophim sees the acquisition of Novastell as a new step in its diversification and the continuation of its growth.
Through this integration, Sophim raises its consolidated sales for 2023 to 36 million euros, with a total workforce of 80.
“Synergies between cosmetics and nutraceuticals are increasingly numerous. This acquisition will enable us to accelerate our growth and bring new products to market more quickly,” says Jacques Margnat, Chairman and CEO of Sophim.
“This acquisition is of particular importance given the convergence of our business models: Novastell, as Sophim, valorizes byproducts from the oil industry to create ingredients for the nutraceutical industry. This match not only reflects our shared values, but also responds to market dynamics, reinforcing the strategic relevance of our merger,” adds Alexis Margnat, Managing Director of Sophim.
An expert in lipids and phospholipids, Novastell offers a large range of nutritional and functional ingredients for Pregnancy & Women health, Memory & Concentration, Digestive health, Stress management, Skin health, Sports Nutrition, Inflammation, Healthy ageing, Brain cognition, Liver protection, Cardiovascular health, etc.
